Impact of PCV7 on invasive pneumococcal disease among children younger than 5 years: a population-based study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 15249298.
- Also identified by PMC identifier 1448372.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We examined the impact of the heptavalent pneumococcal conjugate vaccine (PCV7) on hospital discharge rates for invasive pneumococcal disease among Michigan children younger than 5 years old. After the introduction of PCV7, the hospital discharge rate for children younger than 1 years old was significantly lower than before introduction. We correlated the decreased rates with the introduction and rapid uptake of PCV7. Lack of change in the hospital discharge rates for other age groups likely represents a slower uptake of PCV7 compared with that for children aged younger than 1 year.
Medical subject headings
- Meningococcal Vaccines
- Pneumococcal Infections
- Pneumococcal Vaccines
- Population Surveillance